Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle Proteins | 10 | 2020 | 184 | 3.280 |
Why?
|
| Chromosomal Instability | 7 | 2018 | 20 | 2.260 |
Why?
|
| Colonic Neoplasms | 4 | 2022 | 117 | 2.000 |
Why?
|
| Mitosis | 7 | 2020 | 109 | 1.650 |
Why?
|
| Amyloid beta-Peptides | 3 | 2020 | 46 | 1.520 |
Why?
|
| Alzheimer Disease | 4 | 2020 | 210 | 1.390 |
Why?
|
| Haploinsufficiency | 4 | 2018 | 8 | 1.180 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 123 | 1.130 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 132 | 1.020 |
Why?
|
| Mutation | 6 | 2020 | 818 | 1.020 |
Why?
|
| Liver Neoplasms | 3 | 2016 | 164 | 0.970 |
Why?
|
| Adenocarcinoma | 2 | 2022 | 284 | 0.950 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 1392 | 0.900 |
Why?
|
| Genomic Instability | 3 | 2022 | 33 | 0.830 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 656 | 0.830 |
Why?
|
| Neoplasms | 4 | 2016 | 748 | 0.770 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2020 | 31 | 0.720 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 42 | 0.710 |
Why?
|
| Antimitotic Agents | 2 | 2012 | 5 | 0.710 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 54 | 0.690 |
Why?
|
| Mice | 11 | 2020 | 4399 | 0.690 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2018 | 77 | 0.680 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 150 | 0.660 |
Why?
|
| Brain | 3 | 2020 | 698 | 0.650 |
Why?
|
| Spindle Apparatus | 4 | 2010 | 52 | 0.640 |
Why?
|
| Animals | 15 | 2020 | 9943 | 0.630 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 7 | 0.560 |
Why?
|
| Signal Transduction | 4 | 2016 | 1338 | 0.550 |
Why?
|
| Microtubules | 3 | 2010 | 89 | 0.510 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 114 | 0.460 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 130 | 0.440 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2012 | 52 | 0.410 |
Why?
|
| Centrosome | 1 | 2012 | 10 | 0.400 |
Why?
|
| Schizosaccharomyces | 4 | 2000 | 5 | 0.400 |
Why?
|
| Biological Products | 1 | 2012 | 60 | 0.400 |
Why?
|
| Schizosaccharomyces pombe Proteins | 3 | 2000 | 4 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 1471 | 0.360 |
Why?
|
| Humans | 14 | 2022 | 26789 | 0.360 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 216 | 0.360 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 487 | 0.350 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2009 | 6 | 0.340 |
Why?
|
| Organ Specificity | 2 | 2022 | 81 | 0.340 |
Why?
|
| Genetic Therapy | 1 | 2010 | 116 | 0.340 |
Why?
|
| Fungal Proteins | 3 | 2000 | 72 | 0.320 |
Why?
|
| Aging | 1 | 2016 | 943 | 0.320 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2006 | 80 | 0.320 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2009 | 69 | 0.310 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 145 | 0.310 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2006 | 5 | 0.270 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2006 | 15 | 0.260 |
Why?
|
| Transcription Factors | 2 | 2009 | 511 | 0.260 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 1263 | 0.250 |
Why?
|
| Azoxymethane | 2 | 2015 | 17 | 0.250 |
Why?
|
| HeLa Cells | 3 | 2015 | 206 | 0.240 |
Why?
|
| Cell Cycle | 2 | 2006 | 155 | 0.240 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 160 | 0.240 |
Why?
|
| Apoptosis | 2 | 2015 | 739 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 441 | 0.200 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 37 | 0.200 |
Why?
|
| Transcriptome | 1 | 2022 | 199 | 0.180 |
Why?
|
| Ligases | 2 | 1997 | 18 | 0.180 |
Why?
|
| Aneuploidy | 2 | 2020 | 19 | 0.180 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 19 | 0.170 |
Why?
|
| Chromosome Segregation | 2 | 2012 | 55 | 0.170 |
Why?
|
| Lung | 1 | 2022 | 349 | 0.170 |
Why?
|
| Mice, Knockout | 2 | 2020 | 781 | 0.170 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 186 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 662 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 142 | 0.160 |
Why?
|
| Anaphase | 2 | 1997 | 29 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 1997 | 10 | 0.150 |
Why?
|
| Nuclear Proteins | 2 | 2009 | 245 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 194 | 0.140 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 110 | 0.130 |
Why?
|
| Male | 3 | 2020 | 12854 | 0.130 |
Why?
|
| Models, Animal | 1 | 2016 | 129 | 0.130 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2015 | 2 | 0.130 |
Why?
|
| Glypicans | 1 | 2015 | 3 | 0.130 |
Why?
|
| alpha-Fetoproteins | 1 | 2015 | 18 | 0.120 |
Why?
|
| Pyrroles | 1 | 2015 | 35 | 0.120 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 28 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2015 | 37 | 0.120 |
Why?
|
| Hepatitis B virus | 1 | 2015 | 16 | 0.120 |
Why?
|
| Pancreatitis | 1 | 2015 | 36 | 0.120 |
Why?
|
| Oncogenes | 1 | 2015 | 34 | 0.120 |
Why?
|
| Carcinogens | 1 | 2015 | 37 | 0.120 |
Why?
|
| Hepacivirus | 1 | 2015 | 46 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 57 | 0.120 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 43 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 139 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 125 | 0.110 |
Why?
|
| Zinc Fingers | 2 | 2006 | 26 | 0.110 |
Why?
|
| DNA Damage | 1 | 2015 | 149 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 439 | 0.110 |
Why?
|
| Chemoprevention | 1 | 2012 | 29 | 0.110 |
Why?
|
| Aberrant Crypt Foci | 1 | 2012 | 2 | 0.100 |
Why?
|
| Centrioles | 1 | 2012 | 2 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 79 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2012 | 152 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 49 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 289 | 0.080 |
Why?
|
| Rats, Inbred F344 | 1 | 2009 | 167 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 507 | 0.080 |
Why?
|
| Female | 2 | 2016 | 14434 | 0.080 |
Why?
|
| Transfection | 1 | 2009 | 312 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 673 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 627 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2009 | 282 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2000 | 1034 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2009 | 503 | 0.080 |
Why?
|
| Gene Expression | 1 | 2009 | 406 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 1997 | 33 | 0.070 |
Why?
|
| Genes, cdc | 1 | 2006 | 7 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 376 | 0.070 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2006 | 2 | 0.070 |
Why?
|
| Genomic Imprinting | 1 | 2006 | 4 | 0.070 |
Why?
|
| Rhabdomyosarcoma | 1 | 2006 | 3 | 0.070 |
Why?
|
| Wilms Tumor | 1 | 2006 | 7 | 0.070 |
Why?
|
| Hepatoblastoma | 1 | 2006 | 6 | 0.070 |
Why?
|
| LIM Domain Proteins | 1 | 2006 | 3 | 0.070 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2006 | 4 | 0.070 |
Why?
|
| Leupeptins | 1 | 2006 | 7 | 0.070 |
Why?
|
| Ubiquitin | 1 | 2006 | 24 | 0.070 |
Why?
|
| Nocodazole | 1 | 2006 | 11 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 33 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2006 | 13 | 0.070 |
Why?
|
| Rats | 1 | 2009 | 1544 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 90 | 0.070 |
Why?
|
| Proteasome Inhibitors | 1 | 2006 | 24 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 101 | 0.060 |
Why?
|
| Paclitaxel | 1 | 2006 | 183 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2006 | 143 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2006 | 196 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 2009 | 114 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 130 | 0.050 |
Why?
|
| Temperature | 2 | 2000 | 207 | 0.050 |
Why?
|
| Suppression, Genetic | 1 | 2000 | 5 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2000 | 17 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2000 | 110 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2000 | 115 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 262 | 0.040 |
Why?
|
| Base Sequence | 2 | 1997 | 573 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2000 | 244 | 0.040 |
Why?
|
| Apc6 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 1997 | 1 | 0.040 |
Why?
|
| Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 1997 | 2 | 0.040 |
Why?
|
| G1 Phase | 1 | 1997 | 15 | 0.040 |
Why?
|
| Genes, Suppressor | 1 | 1997 | 6 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1997 | 26 | 0.040 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 1997 | 14 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 38 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 1996 | 80 | 0.030 |
Why?
|
| Phosphorylation | 1 | 1997 | 558 | 0.030 |
Why?
|
| Ceruletide | 1 | 2015 | 7 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2015 | 16 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2015 | 18 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 68 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 44 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 110 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 450 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2015 | 766 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 280 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1994 | 482 | 0.020 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2009 | 2 | 0.020 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Mad2 Proteins | 1 | 2009 | 10 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2009 | 9 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 60 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 122 | 0.020 |
Why?
|
| Genes, Fungal | 2 | 1996 | 7 | 0.020 |
Why?
|
| Cyclins | 1 | 1996 | 8 | 0.010 |
Why?
|
| Metals, Heavy | 1 | 1996 | 9 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 204 | 0.010 |
Why?
|
| Minichromosome Maintenance Complex Component 4 | 1 | 1994 | 1 | 0.010 |
Why?
|
| Minichromosome Maintenance Complex Component 6 | 1 | 1994 | 1 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 1994 | 6 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 1994 | 10 | 0.010 |
Why?
|
| Cell Division | 1 | 1994 | 153 | 0.010 |
Why?
|
| DNA Replication | 1 | 1994 | 49 | 0.010 |
Why?
|
| Phenotype | 1 | 1994 | 664 | 0.010 |
Why?
|